Symptomatologie und klinischer Verlauf bei hospitalisierten Erwachsenen mit Virusinfektionen durch Influenza A und Respiratory Syncytial-Virus (RSV)

Zusammenfassung

Einleitung Zum klinischen Profil und Verlauf von komplizierten Infektionen mit RSV bei Erwachsenen im Vergleich zur Influenza A ist wenig bekannt. Die vorliegende Untersuchung hatte deshalb zum Ziel. prädisponierende Grunderkrankungen, klinisches Profil, Verlauf und Prognose bei hospitalisierten Patienten mit RSV- und Influenza-A-Infektionen miteinander zu vergleichen.

Material und Methode Eingeschlossen wurden Patienten mit RSV- und Influenza-A-Infektionen, die zwischen 1.1.2017 und 31.3.2017 hospitalisiert wurden. Die Diagnostik erfolgte mittels molekularbiologischer Verfahren. Zur Charakterisierung wurden klinische Symptome, Laborparameter sowie disponierende chronische Grunderkrankungen erfasst. Darüber hinaus wurde Verlauf und Schwere der Infektion anhand verschiedener klinischer Parameter einschließlich Beatmungspflichtigkeit und Letalität abgeschätzt.

Ergebnisse Insgesamt wurden 190 Patienten mit Influenza-A- und 98 Patienten mit RSV-Infektion ausgewertet. Sowohl das mittlere Alter als auch die klinische Symptomatologie bei Diagnosestellung waren in beiden Patientengruppen vergleichbar. Nur 2/3 der Patienten zeigten Influenza-typische respiratorische Symptome. Zwischen 13 und 16 % der Infektionen waren nosokomialen Ursprungs. Bezüglich des klinischen Verlaufs mussten insbesondere Patienten mit RSV-Infektion und einer chronischen Lungenerkrankung signifikant häufiger invasiv beatmet werden (odds ratio 10,55 [95 % CI 1,18 – 507,1] p = 0,014).

Schlussfolgerung RSV-Infektionen kommen als häufige Ursache von komplizierten Influenza-ähnlichen Erkrankungen bei älteren, hospitalisierten Patienten in Frage. Im Vergleich zur Influenza A verlaufen RSV-Infektionen insbesondere bei einer chronischen Lungenerkrankung schwerer. Bei beiden Entitäten ist ein nicht unerheblicher Teil der Infektionen nosokomialen Ursprungs, was im Hinblick auf ein erfolgreiches Hygienemanagement eine möglichst rasche Diagnosestellung impliziert.

Abstract

There is little evidence on the clinical characteristics and the course of complicated infections with respiratory syncytial virus (RSV) compared to influenza A in adults. Therefore, the present monocenter study aims to compare infections with RSV and influenza A with regard to potential predisposing factors, clinical profile, course and outcome in hospitalized patient.

Material and methods the study was performed between Jan 1th and March 31 this year and included all hospitalized patients with a Polymerase chain-reaction-(PCR) confirmed infection of influenza A and RSV. Patients were characterized by clinical symptoms at the time of diagnosis, laboratory parameters of inflammation and potential predisposing factors like chronical diseases of heart, lung, kidney, metabolism and tumors. Data on the length of hospital stay, origin of infection (nosocomial), rate of pneumonia, antimicrobial use, need of mechanical ventilation and hospital mortality were obtained to evaluate clinical severity and outcome.

Results A total of 190 patients with Influenza A and 98 patients with RSV were included. Both patient groups did not differ with regard to anthropometric data and clinical symptoms: it was surprising to see that only 2/3 oft all patients exert symptoms of a respiratory infection. 15.3 % of influenza A and 13.3 % RSV infections were defined as being nosocomial. Comparing the clinical course and outcome, patients with RSV infections and chronical disease of the lung had an increased rate of mechanical ventilations (odds ratio 10.55 [95 % CI 1.18 – 507.1] p = 0.014).

Conclusions The present data clearly show that RSV is a frequent pathogen in hospitalized adults with complicated infections in the winter season. RSV infections seems to be more severe compared to influenza A particular in patients with chronic lung disease, but were as frequent as influenza A of nosocomial origin. In this context, an early diagnosis seems to be helpful for a successful infections prevention management under hospital conditions.

Schlüsselwörter

Erwachsene - Influenza A - RSV - klinischer Verlauf

Key words

adults - influenza A - RSV - complicated infections

• Literatur

• 1 Goldstein E, Greene SK, Olson DR. et al. Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City 2003–2011. Influenza Other Resp Viruses 2015; 9: 225-233
• 2 Walsh EF, Falsey AR. Respiratory Syncytial Virus infection in adult populations. Infect Disord Drug Targets 2012; 12: 98-102
• 3 Wang D, Chen L, Ding Y. et al. Viral etiology of medically attended influenza-like illness in children less than five years old in Suzhou, China, 2011–2014. J Med Virol 2016; 88: 1334-1340
• 4 https://www.worldlungfoundation.org ; Stand 20.11.2017
• 5 Moe N, Stegseng IH, Krokstad S. et al. The burden of human metapneumovirus and respiratory syncytial virus infections in hospitalized Norwegian children. J Inf Dis 2017; 216: 110-116
• 6 Canini L, Wollhouse ME, Maines T. et al. Heterogenous shedding of influenza by human subjects and its implications for epidemiology and control. Sci Rep 2016; 14: 6 . doi:10.1038/srep38749
• 7 Robert Koch-Institut. Aktuelle Statistik meldepflichtiger Infektionskrankheiten, Deutschland, 32. Woche. Epidemiol Bulletin; 2017 35. 390
• 8 Ramaekers K, Keyaerts E, Rector A. et al. Prevalence and seasonality of six respiratory viruses during five consecutive epidemic seasons in Belgium. J Clin Virol 2017; 94: 72-78
• 9 https://www.influenza.rki.de ; Stand 20.11.2017
• 10 Iha A, Jarvis H, Fraser C. et al. Respiratory Syncytial Virus. Eur Respir Soc Monogr 2016; 72: 84-109
• 11 Shi T, Balsels E, Wastnedge E. et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis. J Glob Health 2015; 5: 020416 . doi:10.7189/jogh.05.020416
• 12 Jain S, Finelli L. CDC EPIC Study Team. Community-acquired pneumonia among U.S. children. N Engl J Med 2015; 372: 2167-2168
• 13 Schanzer D, Schwartz B. Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontario, Canada. Acad Emerg Med 2013; 20: 388-397
• 14 Salgado CD, Farr BM, Hall KK. et al. Influenza in the acute hospital setting. Lancet Inf Dis 2002; 2: 145-155
• 15 McDonnell WM, Nelson DS, Schunk JE. Should we fear flu fear? Effects of H1N1 influenza fear on ED use. Am J Emerg Med 2012; 30: 275-282
• 16 Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern Ausgabe 2016 gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG). https://www.rki.de/DE/Content/Infekt/IfSG/Falldefinition/falldefinition_node.html
• 17 Ebell MH, Afonso A. A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med 2011; 9: 69-77
• 18 Carrat F, Tachet A, Rouzioux C. et al. Evaluation of clinical case definition of influenza: detailed investigation of patients during the 1995–1996 epidemic in France. Clin Inf Dis 1999; 28: 283-290
• 19 Loubet P, Lenzi N, Valette M. et al. Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Inf 2017; 23: 253-259
• 20 Petridis D, Zarogulidis P, Kallianos A. et al. Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach. Ther Clin Risk Man 2014; 10: 77-86
• 21 Espinosa Y, San Martín C, Torres AA. et al. See comment in PubMed Commons below. Genomic loads and genotypes of respiratory syncytial virus: viral factors during lower respiratory tract infection in Chilean hospitalized infants. Int J Mol Sci 2017; 18: 654 . doi:10.3390/ijms18030654
• 22 Oladokun R, Muloiwa R, Hsiao NY. et al. Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children’s Hospital, Cape Town. BMC Infect Dis 2016; 16: 236 . doi:10.1186/s12879-016-1572-5
• 23 Meier P, Dayer E, Ronco P. et al. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure. Clin Nephrol 2005; 63: 8-21
• 24 Dimopoulos G, Lerikou M, Tsiodras S. et al. Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pul Pharmacol Ther 2012; 25: 12-18
• 25 Hermann B, Lehners N, Brodhun M. et al. Influenza virus infections in patients with malignancies – characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 2017; 36: 565-573
• 26 Cebey-López M, Pardo-Seco J, Gómez-Carballa A. et al. GENDRES network. Bacteremia in children hospitalized with Respiratory Syncytial Virus infection. PLoS One 2016; 11: e0152481 . doi:10.1371/journal.pone.0152481. eCollection 2016
• 27 Yang JH, Huang PY, Shie S. et al. Diagnostic capacity of rapid influenza antigen test: reappraisal with experience from the 2009 H1N1 pandemic. J Microbiol Immunol Inf 2012; 45: 102-107
• 28 DiMaio M, Sahoo MK, Waggoner J. et al. Comparison of Xpert Flu rapid nucleic acid testing with rapid antigen testing for the diagnosis of influenza A and B. J Virol Meth 2012; 186: 137-140
• 29 Apisarnthanarak A, Mundy LM. Rapid testing for pandemic influenza A (H1N1): diagnostic test utility and specimen source. Infect Control Hos Epidemiol 2010; 31: 663-664
• 30 Landry ML. Diagnostic tests for influenza infection. Curr Opin Pediatr 2011; 23: 91-97
• 31 Jung BK, Choi SH, Lee JH. et al. Performance evaluation of four rapid antigen tests for the detection of Respiratory syncytial virus. J Med Virol 2016; 88: 1720-1724
• 32 Tuttle R, Weick A, Schwarz WS. et al. Evaluation of novel second-generation RSV and influenza rapid tests at the point of care. Diagn Microbiol Infect Dis 2015; 81: 171-176
• 33 Inkster T, Ferguson K, Edwardson A. et al. Consecutive yearly outbreaks of respiratory syncytial virus in a haemato-oncology ward and efficacy of infection control measures. J Hosp Infect 2017; 96: 353-359
• 34 Nabeya D, Kinjo T, Parrott GL. et al. The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit. J Med Virol 2017; 89: 1364-1372
• 35 Sayers G, Igoe D, Carr M. et al. High morbidity and mortality of influenza A (H3N2) in a psycho-geriatric facility. Epidemiol Infect 2013; 141: 357-365
• 36 Dramowski A, Aucamp M, Bekker A. et al. Infectious disease exposures and outbreaks at a South African neonatal unit with review of neonatal outbreak epidemiology in Africa. Int J Infect Dis 2017; 57: 79-85
• 37 Aichinger E, Schnitzler P, Heeg K. et al. Contributing and terminating factors of a large RSV outbreak in an adult hematology and transplant unit. PLoS Curr 2014; 6 pii: ecurrents.outbreaks.3bc85b2a508d205ecc4a5534ecb1f9be.
• 38 Malavaud S, Malavaud B, Sandres K. et al. Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation 2001; 72: 535-537
• 39 Hermann B, Lehners N, Brodhun M. et al. Influenza virus infections in patients with malignancies – characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 2017; 36: 565-573
• 40 Lee N, Lui GC, Wong KT. et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013; 57: 1069-1077